Sponsored Content
View European Lung Cancer Conference (ELCC) satellite symposium on demand
Now you can view on demand this satellite symposium which was conducted on the 22nd of March at the European Lung Cancer Congress (ELCC) in Prague.
In this “Molecular Tumor Board” set up, an oncologist, pathologist, and molecular biologist discuss biomarker testing in non-small cell lung cancer (NSCLC) from their own perspectives and experiences.
You will get an informative summary of the current biomarker testing needs based on the targeted therapy landscape, hear a discussion about the role of liquid biopsy testing including experience of its implementation in a concurrent manner to tissue testing, and learn how rapid NGS enables labs to provide actionable biomarker profiles in 3 days.
Speakers:
- Francesco Passiglia, University of Turin Hospital, Turin, Italy
NSCLC: Oncologists’ perspective on biomarker testing needs
- Fernando López-Rios, Hospital Universitario 12 de Octubre, Madrid, Spain
When tissue is the issue – optimising rapid liquid biopsy testing in NSCLC
- Morten Grauslund
Copenhagen University, Hospital, Copenhagen, Denmark